INTRODUCTION
In the course of some preliminary observations on the effect of ACTH in multiple myeloma we were intrigued by evidence of substantial decrease in the concentration of serum protein and diminution of Bence-Jones proteinuria (1) . As in other forms of malignancy, response to steroid therapy has proven somewhat varied in the hands of different investigators. Pearson, Eliel, and Talbott (2) mentioned the inefficacy of adrenocorticotropin in plasma cell myeloma. Engle and Barr (3) treated three patients with the same substance and noted little clinical improvement. They found no change in the electrophoretic pattern or in the concentration of plasma protein. In other instances, the results have been similar to those of the authors and include reduction in concentration of serum protein as described by Bethell (3) and other investigators (4) ; decreased excretion of Bence-Jones protein (3); disappearance of hypercalcemia (3, 4) ; and clinical improvement (such as loss of bone pain [3r, better appetite with gain in weight [3, 4] , and increased hematocrit). Our own experience also indicates that adrenocorticotropin diminishes rather than aggravates the rate of skeletal decalcification. This impression has been gained through careful observation of three patients who were hospitalized for metabolic study. That it may also lead occasionally to a prolonged remission was suggested by the clinical response of one of our three subjects treated with this hormone. Although other workers have investigated nitrogen and mineral exchanges in myeloma (5- 11), their findings do not appear pertinent to the present discussion.
PROCEDURE AND METHODS
The patients were admitted to the Metabolism Ward where they were under continuous observation. The urine was analyzed daily for sodium, potassium, phosphorus, chloride, and nitrogen; aliquots of the 24-hour collections of urine were saved and pooled in periods of five days, and the analyses repeated on the pooled samples. This served as an added check on the accuracy of the daily work. Stools were separated at intervals of five days with the use of carmine markers and analyzed for the same constituents as in the case of urine. Sample diets, duplicating the menus of the patients, were prepared at intervals of ten days, homogenized, sampled, and analyzed to determine intake. Emeses and dietary rejects were treated in the same manner as sample diets, analyzed separately, and appropriate corrections of intake were made. Blood was collected in the postabsorptive state from an arm vein with the least possible stasis, and after prompt separation of the serum, determinations were made of total serum protein, albumin, globulin, sodium, chloride, potassium, calcium, and phosphorus. The analytical methods used were as follows: Aliquots of diet, urine, and emesis were ashed in a muffle furnace at a temperature not exceeding 4500 C. Sodium and potassium determinations were performed directly on diluted specimens of urine and (blood) serum, with the use of the Beckman flame photometer. With the exception of nitrogen and chloride, the other substances were determined from the ashed filtrates. Urinary, fecal, and dietary calcium were determined by the gravimetric method of Washburn and Shear (12) , serum calcium by the method of Van Slyke and Sendroy (13) , phosphorus by the gravimetric method of Washburn and Shear (12) , and a modification of the colorimetric method of Fiske and Subbarow (14) , nitrogen by the Hiller, Plazin, and Van Slyke modifications of the Kjeldahl procedure (15) , chlorides by modification of the Volhard method (16) (17) (18) , plasma proteins by a modification of the Howe sodium sulfate method (19) as described by Majoor (20) , and urinary protein by the method of Hiller, Greif, and Beckman (21) , serum and urine uric acid by modification of the methods of Kalckar (22) and Praetorius (23) . 103 The alterations in the exchanges of nitrogen, calcium, phosphorus, and electrolytes associated with the administration of ACTH 2 to these three patients, were in many respects similar to the effects observed in normal subjects and in various other 2 The ACTH used in this study was supplied by Armour & Company. All by a period of nitrogen equilibrium. The response to ACTH at a dosage of 40 mg. per day intramuscularly was prompt. Urinary nitrogen increased markedly and the nitrogen balance became strongly negative (Table I ). The patient continued to lose nitrogen in progressively increasing B. Calcium balance: The average calcium intake was 624 mg. per day with a calcium/phosphorus ratio of 0.6. The calcium balance was consistently negative since the amount excreted in the stool was slightly in excess of the intake. (Figure 2 and Table I .) Urinary calcium averaged 50 to 60 mg. during control periods but increased considerably while the patient was receiving ACTH (Table III) . Whether this increase should be attributed to ACTH or to the acute inflammatory process from which he ultimately succumbed is uncertain. There were no important changes in the concentration of serum calcium, and fecal excretion of calcium remained relatively constant.
C. Phosphorus balance: The administration of ACTH increased both the urinary and fecal excretion of phosphorus and the balance became strongly negative. (See Figure 1 and Table I .)
The theoretical phosph6rus balance and the nitrogen/phosphorus ratios have not been reported for this patient since the balance study was short and complicated in its terminal phases by an acute febrile illness.
D. Sodium, chloride, and potassium balances:
Moderate losses of sodium unaccompanied by similar losses of chloride occurred in control periods. During the first period on ACTH both sodium and chloride were retained in large amounts (Figure 3 and Table I ). Chloride continued to be retained in the second ACTH period although in much smaller amounts. "Escape" from the effect of the hormone occurred in the final period with release of large and approximately equivalent quantities of both elements. The potassium balance followed that of nitrogen rather closely and was strongly negative during administration of corticotropin. No significant changes in the concentration of serum electrolytes occurred.
E. Serum proteins: Prior to therapy with ACTH the concentration of serum protein averaged 12 Gm. per cent, of which 7.5 Gm. per cent precipitated as globulin at 18.5 per cent saturation with sodium sulphate (Figure 4) . After ten days treatment with corticotropin, the globulins separating at 18.5 per cent saturation were reduced to 4 114 Gm. per cent and the total serum protein had decreased to approximately 8 Gm. per cent.
F. Urinary proteins: The amount of protein excreted in the urine of J. D. was much less than that of the other two patients, although his concentration of serum proteins was the highest. Despite the marked catabolic effect associated with ACTH therapy and decrease in concentration of serum protein, the urinary protein upon termination of treatment continued to be excreted at about twothirds of the control level ( Figure 4 and Table II) . More prolonged and intensive administration of ACTH was accompanied by greater proportionate reductions in the proteinuria of J. M. and S. M. Figure 6 anu Table III ). Fecal calcium, on the other hand, increased moderately so that the net balance was negative both during the control periods and during periods of therapy (Figure 8) . However, the loss of calcium was greater during the initial control periods than at any other time.
C. Phosphorus balance: Administration of ACTH in amounts of 40 and later 80 mg. per day was associated witb a negative phosphorus balance ( Figure 5 and Table IV) . It was of some interest that the excretion of phosphorus in urine did not increase appreciably and that the loss of phosphorus was largely the result of a considerable increase in fecal phosphorus (Figure 8) . Computation of the theoretical phosphorus balance and the nitrogen/ phosphorus ratios suggested that during periods of corticotropin therapy a tissue poor in phosphorus was being catabolized (Tables IV and V). D. Serum proteins: The alpha globulin component of the serum proteins was markedly increased initially, averaging 3 Gm. per cent. There was a gradual decrease in this fraction during the course of ACTH administration to a final value of 2.0 Gm. per cent (Figure 7 ). E. he was essentially in nitrogen equilibrium during the first three control periods and during the first two ACTH periods when he received 100 mg. of hormone daily. However, upon increasing the dose to 200 mg. a day, a marked catabolic effect was observed, and this effect continued despite reduction in the dose from 200 to 100 mg. in periods IX, X, and XI. Administration of 50 mg. of testosterone proprionate daily (periods XII through XIV) gradually reversed the strongly negative nitrogen balance and brought about nitrogen equilibrium despite continuation of ACTH in amounts of 100 mg. (Figure 9 and Table VII).
B. Calcium balance: The average daily calcium intake was 590 mg. and the calcium/phosphorus ratio was approximately 0.6. The amount of calcium intake and calcium/phosphorus ratio were somewhat suboptimal according to current concepts of calcium requirement (27) . However, there is no reason to suppose that a normal subject ingesting a similar diet would have been in negative calcium balance. Nevertheless, the patient was in consistently negative calcium balance throughout control periods and periods of ACIH administration. Urinary calcium was reduced from an average daily control value of 223 mg. to 175 mg. during ACTH periods IX, X, and XI (Table III) . The concentration of serum calcium fell progressively from a control value of 10.1 mg. per cent to a low of 7.2 mg. per cent ( Figure 10 and Table  VI ). The latter value was observed when the concentration of the serum proteins had fallen to 4.7 Gm. per cent and was quite possibly related to the hypoproteinemia. Fecal excretion of calcium remained relatively constant (Figure 8 ) .
C. Phosphorus balance: The administration of ACTH increased both the urinary and fecal excretion of phosphorus, and the balance became strongly negative (see Figures 9 and 10) . As with patient J. M., the theoretical phosphorus balance was calculated according to the method of Reifenstein, Albright, and Wells (28) (See Tables V and  VII) . During the first three periods (Control) there was very little unaccountable phosphorus. In the next four ACTH periods, there were losses of phosphorus in excess of what one would predict from the nitrogen and calcium balances, suggesting catabolism of a phosphorus rich tissue. These were followed by four periods (VIII, IX, X, and XI) when the theoretical phosphorus balance was more negative than the actual phosphorus balance and hence possibly indicated catabolism of tissue of low phosphorus content. The simultaneous administration of both testosterone propionate (50 mg. per day) and ACTH (100 mg. per day) led to phosphorus retention in spite of a continued negative calcium balance and nitrogen equilibrium (Periods XII through XV). Thus, it is apparent that under the experimental conditions the anabolic effect of testosterone was exhibited more strongly with respect to phosphorus than to nitrogen. Whether this points to resynthesis of myeloma tissue or has a different explanation cannot be determined from the information available.
When the concentration of potassium in the serum fell below 3 mEq. per liter during ACTH therapy, extra potassium as citrate was given on three separate occasions (see Figure 9 ). The urinary phosphorus decreased each time coincident with potassium administration. The ingestion of potassium did not alter the nitrogen balance which remained strongly negative and hence in this respect also did not parallel the phosphorus exchange.
D. Sodium, chloride, and potassium balances: The response to prolonged ACTH administration was variable and complicated as shown by the sodium and chloride balances ( Figure 11 and Table  VII ). An initial strongly positive salt balance occurred in Period IV when the hormone was first given and was followed by a state approaching equilibrium in Period V. With the increase in ACTH dose to 200 mg. per day in Period VI, salt retention again became marked, only to be followed by salt loss in Period VIII. It seems probable that the negative balance in the latter period represented "escape" at least in part from the action of the hormone since the increase in urinary sodium and chloride preceded ingestion of supplementary potassium. Although administration of potassium was continued into Period IX, a cycle of salt accumulation developed again which lasted through most of Period X. The reverse phenomenon was noted in Periods XI and XII. Thus, the entire duration of ACTH and testosterone therapy seems to have been characterized by alternating cycles of salt retention and loss which may well be related to the transient shifts of water, sodium, and chloride into the extracellular space as described by Levitt and Bader (29) . The final discontinuance of ACTH in Period XVII was dictated by a toxic psychosis and hypopotassemia for which potassium citrate was given for the third time in doses equivalent to 8 Gm. of potassium daily. As a result, more than 700 mEq. of potassium were retained and 600 mEq. of sodium were lost in five days. The effect on the chloride balance was comparatively minor and amounted to a negative balance of 73 mEq. As sodium and chloride loss and potassium retention are distinctive features of ACTH withdrawal, it is probable that the unusually large storage of potassium may have promoted a loss of cell sodium and, therefore, an exceptionally large sodium diuresis. The usual excretion of potassium in excess of intake was observed during administration of corticotropin ( Figure 11 ). Extra potassium as citrate was given orally in Periods VIII, IX, XII, and XVII, and as chloride intravenously (Period XV) to combat hypopotassemia. Although potassium was retained during the time of administration of each supplement, the effect on the concentration in serum was fleeting.
E. Serum proteins: This patient was the only one of the three who had a relatively normal pattern of plasma proteins, both by electrophoresis and by the method of salt fractionation (see Table  VI ). At the outset of the balance study the gamma globulin components were slightly elevated. However, during prolonged administration of ACTH the concentrations of both albumin and globulin decreased progressively ( Figure 12 ) and a moderate hypoproteinemia developed. Simple dilution was not considered to be a causal factor since the value of the packed erythrocytes remained essentially unchanged, and the body weight decreased.
F. Urinary proteins: There was a significant reduction in the excretion of Bence-Jones protein in the urine (Figure 12 ). An average of about 9
Gm. of protein was recovered per day from the urine during control periods and there was little change after administering ACTH for ten days in daily doses of 100 mg. When the dose of ACTH was increased to 200 mg., the proteinuria decreased after eight days to approximately 2.0 Gm. per day, and by the fifteenth day from 0.7 to 0.8 Gm. per day, within which range it remained until the patient left the hospital two months later (Table II) .
G. Uric acid: Quantitative determinations of the excretion of uric acid were made only in the case of S. M. (Figure 13) . The lin fraction in the two patients who exhibited this deviation. The regression in Bence-Jones protein in the urine did not strictly parallel the decrease in plasma protein, but in one patient, S. M., appeared to be more closely related to the development of a strongly negative nitrogen balance. The failure of some investigators to observe changes in plasma protein or proteinuria in myeloma may indicate inadequate dosage or duration of application of the therapeutic agent rather than refractoriness of the disease. This seems to be born out in the response of J. M. and S. M. who showed little effect of treatment with small doses of adrenocorticotropin and definite effects when the dosage was substantially increased.
Calcium and phosphorus exchanges
Skeletal decalcification in multiple myeloma is commonly observed as a late manifestation of the disorder and appears in part in the form of discrete osteolytic lesions and in part as generalized osteoporosis. The discrete areas of decalcification are produced by nests of tumor cells which cause reabsorption of the surrounding bone salts. The degree of calciuria may well be a reflection of this process (30, 31) , and as such, an indication of the activity and extensiveness of the disease. When hypercalcemia occurs one may suspect, as suggested by Albright and Reifenstein (32) , that the dissolution of bone salts is contributing calcium to the blood stream at a more rapid rate than it can be cleared by the kidneys. Since renal function is often seriously impaired in the terminal phases of myeloma, both hypercalcemia and hyperphosphatemia may occur without marked hypercalciuria. This appears to have been the situation in the case studied by Bulger, Dixon, and Barr (5). Another factor in our patients which may have contributed to the loss of calcium, was the presence of bone pain and pathological fractures in two individuals, J. M. and S. M. Both were relatively inactive and spent a considerable portion of their time in bed prior to therapy. Some of the decalcification in these men could well have been the result of the partial immobilization associated with their discomfort, since this in itself leads to negative calcium balance even in healthy subjects (33) (26) as well as other tissues, as evinced by production of negative balances under intensive therapy, it appeared to increase the rate of decalcification only in J. D. The other two patients who became more active due to euphoria, increased feeling of well-being, and later toxic psychosis associated with the administration of the hormone, showed a moderate decrease in calciuria. The possibility must not be overlooked that a recession in the activity of the tumor growth may have been a contributing factor also. In favor of this was the observation that Bence-Jones proteinuria was greatly lessened in both these men, much more so than in patient J. D. In one, S. M., there was a gradual fall in the level of serum calcium, but whether this represented a decrease in the activity of the osteolytic process or in the calcium binding by plasma protein, which also decreased in concentration, is not clear. Loss of calcium from the body appears to have been mainly by excretion in the urine, since fecal excretions were on the average nearly equal to intake. However, in J. M. the mean fecal calcium increased during the periods of ACTH therapy, while in S. M. it revealed only the usual period-to-period fluctuation.
In the case of phosphorus, ACTH not only increased the amount in the urine, but also that appearing in the stools. This was particularly noticeable in patient S. M. who about tripled his excretion of fecal phosphorus during the time the larger doses of hormone were given ( Figure 8A and B) . Excessive amounts of calcium did not appear in the stools of this man so that the shift in partition of phosphorus from urine toward feces cannot be related to calcium. It is of some interest that the excretion of phosphorus in urine was sharply reduced during those days when a positive potassium balance was achieved by the ingestion of potassium citrate. The possibility that the decrease in urinary phosphorus resulted from alkalinization induced by potassium citrate must be considered. While it is generally conceded that acidosis increases the excretion of urinary phosphate, the observations of Pitts and Alexander (34) on the dog do not support the view that the converse is produced by alkalosis. It would seem that the phosphate buffer system is equally important, both in states of acidosis and alkalosis and that the availability of phosphorus might be the major factor determining its excretion. The interdependence of potassium and phosphorus in cellular metabolism may have required retention of the latter when potassium was entering cells. The catabolic effect on nitrogen excretion, however, was not abolished by potassium and in this respect differed from the action of potassium chloride in the rat, as reported by Whitney and Bennett (35) .
The agitation and anxiety which had gradually developed on prolonged treatment of two patients with adrenocorticotropin and which was at first suspected to be associated with the hypopotassemia, seemed to be little influenced by potassium retention accompanying supplementation of the diet, and we were unable to confirm the temporary improvement in psychotic behavior reported (36) when potassium deficiency was relieved. It is true that the concentration of potassium in the serum increased each time the element was ingested in large doses, but there was no salutary effect on the patient's behavior. Possibly, more prolonged or more vigorous potassium therapy was indicated and in view of the observations of others (36) would seem to warrant further investigation.
Although one of our three patients has sustained a remission in the course of his disease, the authors wish to emphasize that no conclusion should be drawn as to the therapeutic benefit of ACTH in multiple myeloma. SUMMARY 1. Three cases of multiple myeloma are reported in whom the effect of administration of ACTH was observed during hospitalization in the Metabolic Unit.
2. Decreases in the concentration of serum proteins were observed in all three patients during therapy. In two, the effect was mainly on the abnormal globulin, while in the third all components of the serum proteins decreased. Proteinuria also decreased and in one patient at least, the di-119
